- Home
- HSCS vs TTNP Comparison
HSCS vs TTNP Comparison
Compare HSCS & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- TTNP
- Stock Information
- Founded
- HSCS 2007
- TTNP 1991
- Country
- HSCS United States
- TTNP United States
- Employees
- HSCS N/A
- TTNP N/A
- Industry
- HSCS Medical Specialities
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HSCS Health Care
- TTNP Health Care
- Exchange
- HSCS Nasdaq
- TTNP Nasdaq
- Market Cap
- HSCS 2.8M
- TTNP 3.4M
- IPO Year
- HSCS 2022
- TTNP 1996
- Fundamental
- Price
- HSCS $3.30
- TTNP $3.73
- Analyst Decision
- HSCS Strong Buy
- TTNP
- Analyst Count
- HSCS 2
- TTNP 0
- Target Price
- HSCS $13.00
- TTNP N/A
- AVG Volume (30 Days)
- HSCS 8.7K
- TTNP 29.7K
- Earning Date
- HSCS 03-13-2025
- TTNP 05-14-2025
- Dividend Yield
- HSCS N/A
- TTNP N/A
- EPS Growth
- HSCS N/A
- TTNP N/A
- EPS
- HSCS N/A
- TTNP N/A
- Revenue
- HSCS N/A
- TTNP N/A
- Revenue This Year
- HSCS N/A
- TTNP N/A
- Revenue Next Year
- HSCS N/A
- TTNP N/A
- P/E Ratio
- HSCS N/A
- TTNP N/A
- Revenue Growth
- HSCS 261.17
- TTNP N/A
- 52 Week Low
- HSCS $2.36
- TTNP $3.03
- 52 Week High
- HSCS $13.50
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- HSCS 55.49
- TTNP 50.05
- Support Level
- HSCS $2.97
- TTNP $3.51
- Resistance Level
- HSCS $3.83
- TTNP $3.76
- Average True Range (ATR)
- HSCS 0.28
- TTNP 0.23
- MACD
- HSCS 0.06
- TTNP -0.00
- Stochastic Oscillator
- HSCS 56.20
- TTNP 37.31
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.